Qifan Zhou

Shenzhen Key Laboratory Of Small Molecule Drug Discovery And Synthesis
Shenzhen, 518000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Dual Inhibition of PB2 and JAK2 for Influenza: A Strategy Combining Antiviral and Host-Directed Immune Modulation.

Dual Inhibition of PB2 and JAK2 for Influenza: A Strategy Combining Antiviral and Host-Directed Immune Modulation.

Journal: Molecules (Basel, Switzerland)

Published: December 22, 2025

Carrier-free GSH-responsive in situ nanoreactor for copper-overload augment cuproptosis/chemodynamic therapy.

Carrier-free GSH-responsive in situ nanoreactor for copper-overload augment cuproptosis/chemodynamic therapy.

Journal: Materials today. Bio

Published: December 15, 2025

Rational design of dual PB2/JAK2 inhibitors achieving balanced antiviral and host-directed immunomodulatory effects.

Rational design of dual PB2/JAK2 inhibitors achieving balanced antiviral and host-directed immunomodulatory effects.

Journal: European journal of medicinal chemistry

Published: November 20, 2025

Ligand-based design and optimization of tecovirimat derivatives as potent antiviral agents against monkeypox virus.

Ligand-based design and optimization of tecovirimat derivatives as potent antiviral agents against monkeypox virus.

Journal: European journal of medicinal chemistry

Published: September 15, 2025

Identification and Evaluation of Non-Nucleosidic MTase Inhibitors against SARS-CoV-2 nsp14 with Lower-Micromolar Anti-Coronavirus Activity.

Identification and Evaluation of Non-Nucleosidic MTase Inhibitors against SARS-CoV-2 nsp14 with Lower-Micromolar Anti-Coronavirus Activity.

Journal: ACS infectious diseases

Published: July 17, 2025

Preclinical characterization and anti-RSV efficacy of an oral C-nucleoside derivative.

Preclinical characterization and anti-RSV efficacy of an oral C-nucleoside derivative.

Journal: Acta pharmaceutica Sinica. B

Published: April 08, 2025

Mini review: SHEN26, a novel oral antiviral drug for COVID-19 treatment.

Mini review: SHEN26, a novel oral antiviral drug for COVID-19 treatment.

Journal: Bioorganic & medicinal chemistry letters

Published: February 21, 2025

Discovery of Novel Thiophene-Based Baloxavir Derivatives as Potent Cap-Dependent Endonuclease Inhibitors for Influenza Treatment.

Discovery of Novel Thiophene-Based Baloxavir Derivatives as Potent Cap-Dependent Endonuclease Inhibitors for Influenza Treatment.

Journal: Journal of medicinal chemistry

Published: December 10, 2024

Anti-SARS-CoV-2 prodrug ATV006 has broad-spectrum antiviral activity against human and animal coronaviruses.

Anti-SARS-CoV-2 prodrug ATV006 has broad-spectrum antiviral activity against human and animal coronaviruses.

Journal: Acta pharmaceutica Sinica. B

Published: October 14, 2024

Development of pyrimidone derivatives as nonpeptidic and noncovalent 3-chymotrypsin-like protease (3CLpro) inhibitors with anti-coronavirus activities.

Development of pyrimidone derivatives as nonpeptidic and noncovalent 3-chymotrypsin-like protease (3CLpro) inhibitors with anti-coronavirus activities.

Journal: Bioorganic chemistry

Published: September 26, 2024

Identification of adenosine analogues as nsp14 N7‑methyltransferase inhibitors for treating coronaviruses infection.

Identification of adenosine analogues as nsp14 N7‑methyltransferase inhibitors for treating coronaviruses infection.

Journal: Bioorganic chemistry

Published: September 06, 2024

Broad-Spectrum Antiviral Activity of the Orally Bioavailable Antiviral ATV014 Against Multiple Coronaviruses.

Broad-Spectrum Antiviral Activity of the Orally Bioavailable Antiviral ATV014 Against Multiple Coronaviruses.

Journal: MedComm

Published: August 07, 2024

Showing 1-12 of 17

Last Updated: 09/26/2026